Technical Analysis for MATN - Mateon Therapeutics Inc

Grade Last Price % Change Price Change
grade B 0.1872 -0.16% -0.0003
MATN closed down 0.16 percent on Wednesday, July 1, 2020, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical MATN trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction -0.16%
Upper Bollinger Band Walk Strength -0.16%
BB Squeeze + Upper Band Touch Range Contraction -0.16%
Overbought Stochastic Strength -0.16%
Upper Bollinger Band Touch Strength -0.16%
20 DMA Support Bullish -1.47%
Older signals for MATN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mateon Therapeutics, Inc., formerly OXiGENE, Inc., is a biopharmaceutical company. The Company is focused on the development of vascular disrupting agents (VDAs) for the treatment of cancer. The Company is engaged in developing two clinical stage investigational drugs: VDAs-CA4P and OXi4503. Its lead compound is CA4P, which is also known as combretastatin A4-phosphate, fosbretabulin tromethamine, fosbretabulin and ZYBRESTAT. VDAs selectively targets the vasculature of cancer tumors and obstructs a tumor's blood supply without disrupting the blood supply to normal tissues. VDAs are in a class of drugs called vascular targeted therapies (VTTs), which also includes anti-angiogenic agents (AAs). CA4P is a reversible tubulin binding agent that selectively targets the endothelial cells that make up the blood vessel walls in solid tumors. The Company is pursuing the development of a product candidate, OXi4503, which is a dual-mechanism VDA.
Medicine Medical Specialties Cancer Clinical Medicine Biopharmaceutical Treatment Of Cancer Solid Tumors Cancer Treatments Tumor Angiology Angiogenesis

Is MATN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.35
52 Week Low 0.076
Average Volume 127,039
200-Day Moving Average 0.1951
50-Day Moving Average 0.1750
20-Day Moving Average 0.1803
10-Day Moving Average 0.1832
Average True Range 0.0144
ADX 9.44
+DI 17.3632
-DI 15.9204
Chandelier Exit (Long, 3 ATRs ) 0.1543
Chandelier Exit (Short, 3 ATRs ) 0.2007
Upper Bollinger Band 0.1918
Lower Bollinger Band 0.1688
Percent B (%b) 0.8
BandWidth 12.7565
MACD Line 0.0042
MACD Signal Line 0.0032
MACD Histogram 0.0011
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1914
Resistance 3 (R3) 0.1919 0.1909 0.1907
Resistance 2 (R2) 0.1909 0.1899 0.1907 0.1905
Resistance 1 (R1) 0.1891 0.1892 0.1886 0.1886 0.1902
Pivot Point 0.1881 0.1881 0.1879 0.1879 0.1881
Support 1 (S1) 0.1863 0.1871 0.1858 0.1858 0.1842
Support 2 (S2) 0.1853 0.1864 0.1851 0.1839
Support 3 (S3) 0.1835 0.1853 0.1837
Support 4 (S4) 0.1830